Hypothyroidism Linked to Increased Dementia Risk, Especially in Medicated Patients
Individuals with hypothyroidism face a heightened risk of developing dementia, particularly among those undergoing medication for the endocrine disorder, highlighting the importance of early detection and management of thyroid function in cognitive health.
March 2023
Luxotonic Signals in Prefrontal Cortex Unveiled as Key Mediators of Light's Influence on Mood
Researchers elucidate the role of luxotonic signals in the human prefrontal cortex as critical substrates for modulating mood and cognition in response to light exposure, providing novel insights into the mechanisms underlying the impact of light on mental well-being.
March 2023
Oral Sabizabulin Demonstrates Mortality Reduction in High-Risk COVID-19 Patients
Treatment with oral Sabizabulin results in a significant 24.9% absolute reduction in deaths among hospitalized adults at high risk for severe COVID-19, highlighting its potential as a therapeutic option in combating the pandemic.
March 2023
FDA Recommends Modification of Vaccines to Include Omicron BA 4/5 Component
The FDA advises the inclusion of an Omicron BA 4/5 spike protein component in COVID-19 vaccines, prompting efforts to develop modified vaccine formulations to enhance protection against emerging variants of concern.
March 2023
Exploring the Relationship Between Diabetes Treatment and Hepatocellular Cancer Risk
Researchers investigate the effect of diabetes medications and glycemic control on the risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease, shedding light on potential therapeutic strategies to mitigate cancer risk in this population.
March 2023
